EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Electrochemical Technology for the Detection of Tau Proteins as a Biomarker of Alzheimer’s Disease in Blood

Jianman Wang, Xing Lu, Yao He

Biosensors · 2025

DOI: 10.3390/bios15020085 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biosensors, 2025. Verfasst von Jianman Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Macao Translational Medicine Center, Macau University of Science and Technology, Taipa 999078, Macau SAR, China. Hauptthemen laut MEDLINE: tau Proteins, Alzheimer Disease, Biosensing Techniques, Electrochemical Techniques. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Science and Technology Development Fund, Macau SAR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a prevalent neurodegenerative disorder and a significant cause of dementia in elderly individuals, with a growing prevalence in our aging population. Extracellular amyloid-β peptides (Aβ), intracellular tau proteins, and their phosphorylated forms have gained prominence as critical biomarkers for early and precise diagnosis of AD, correlating with disease progression and response to therapy. The high costs and invasiveness of conventional diagnostic methods, such as positron emission tomography (PET) and magnetic resonance imaging (MRI), limit their suitability for large-scale or routine screening. However, electrochemical (EC) analysis methods have made significant progress in disease detection due to their high sensitivity, excellent specificity, portability, and cost-effectiveness. This article reviews the progress in EC biosensing technologies, focusing on the detection of tau protein biomarkers in the blood (a low-invasive, accessible diagnostic medium). The article then discusses various EC sensing platforms, including their fabrication processes, limit of detection (LOD), sensitivity, and clinical potential to show the role of these sensors as transformers changing the face of AD diagnostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

tau ProteinsAlzheimer DiseaseBiosensing TechniquesElectrochemical TechniquesHumansBiomarkersAmyloid beta-Peptides

Stichwörter der Autor:innen

Alzheimer’s disease (AD)biosensorselectrochemical detectionpoint-of-care diagnosticstau proteins

Substanzen

tau ProteinsBiomarkersAmyloid beta-Peptides

Autor:innen und Institutionen

  • Macao Translational Medicine Center, Macau University of Science and Technology, Taipa 999078, Macau SAR, China.
  • School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Taipa 999078, Macau SAR, China.
  • Macao Institute of Materials Science and Engineering, Macau University of Science and Technology, Taipa 999078, Macau SAR, China.
  • Suzhou Key Laboratory of Nanotechnology and Biomedicine, Institute of Functional Nano and Soft Materials (FUNSOM), Soochow University, Suzhou 215123, China.

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • Science and Technology Development Fund, Macau SAR
  • China Postdoctoral Science Foundation
  • National Key R&D Program of China

Zitieren

APA

Wang, J., Lu, X., & He, Y. (2025). Electrochemical Technology for the Detection of Tau Proteins as a Biomarker of Alzheimer’s Disease in Blood. Biosensors. https://doi.org/10.3390/bios15020085

Vancouver

Wang J, Lu X, He Y. Electrochemical Technology for the Detection of Tau Proteins as a Biomarker of Alzheimer’s Disease in Blood. Biosensors. 2025. doi:10.3390/bios15020085

BibTeX
@article{Wang2025,
  author = {Wang, Jianman and Lu, Xing and He, Yao},
  title = {Electrochemical Technology for the Detection of Tau Proteins as a Biomarker of Alzheimer’s Disease in Blood},
  journal = {Biosensors},
  year = {2025},
  doi = {10.3390/bios15020085}
}
Kostenlos starten →